{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:53:37Z","timestamp":1790916817261,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":169,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101294","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:41:23Z","timestamp":1782279683000},"page":"101294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A comparative analysis of cytotoxic effects: Lactobacillus reuteri Extract vs. Newcastle Disease Virus in human colorectal cancer (HT-29 cell line)"],"prefix":"10.1016","volume":"48","author":[{"given":"Ali Nemani","family":"Khiavi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein","family":"Lahimchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashkan Mashaheri","family":"Fard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Heydari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8165-1344","authenticated-orcid":false,"given":"Seyed Kiarash","family":"Aghayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ctarc.2026.101294_bib0001","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1158\/1541-7786.MCR-23-0411","article-title":"Updating the definition of cancer","volume":"21","author":"Brown","year":"2023","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101294_bib0002","doi-asserted-by":"crossref","first-page":"5","DOI":"10.34172\/mejdd.2022.251","article-title":"Gastrointestinal and pancratohepatobiliary cancers: a comprehensive review on epidemiology and risk factors worldwide","volume":"14","author":"Hormati","year":"2022","journal-title":"Middle East. J. Dig. Dis."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101294_bib0003","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.3390\/biomedicines12081801","article-title":"Overcoming cancer resistance: strategies and modalities for effective treatment","volume":"12","author":"Koirala","year":"2024","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101294_bib0004","doi-asserted-by":"crossref","first-page":"166","DOI":"10.5005\/jp-journals-10018-1241","article-title":"Hepatic metastasis from colorectal cancer","volume":"7","author":"Valderrama-Trevi\u00f1o","year":"2017","journal-title":"EuroAsian J. Hepatogastroenterol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101294_bib0005","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2174\/0115733947259130231003044741","article-title":"Early detection of colorectal cancer: conventional techniques and current biomarkers","volume":"20","author":"Ahmadpour","year":"2024","journal-title":"Curr. Cancer Ther. Rev."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101294_bib0006","first-page":"3009","article-title":"Determining the survival rate of colorectal cancer in Iran: a systematic review and meta-analysis","volume":"19","author":"Tahmasbi","year":"2018","journal-title":"APJCP"},{"issue":"13","key":"10.1016\/j.ctarc.2026.101294_bib0007","doi-asserted-by":"crossref","first-page":"7470","DOI":"10.3390\/ijms25137470","article-title":"Innovative strategies to combat 5-Fluorouracil resistance in colorectal cancer: the role of phytochemicals and extracellular vesicles","volume":"25","author":"Barathan","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ctarc.2026.101294_bib0008","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.omto.2019.10.007","article-title":"Oncolytic viruses for cancer therapy: barriers and recent advances","volume":"15","author":"Zheng","year":"2019","journal-title":"Mol. Ther. Oncolytics."},{"key":"10.1016\/j.ctarc.2026.101294_bib0009","first-page":"349","article-title":"Oncolytic viruses and the immune system: the dynamic duo","volume":"17","author":"De Matos","year":"2020","journal-title":"MTMCD"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101294_bib0010","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.trecan.2022.10.003","article-title":"The emerging field of oncolytic virus-based cancer immunotherapy","volume":"9","author":"Ma","year":"2023","journal-title":"Trends. Cancer"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101294_bib0011","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrd4663","article-title":"Oncolytic viruses: a new class of immunotherapy drugs","volume":"14","author":"Kaufman","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ctarc.2026.101294_bib0012","first-page":"1","article-title":"Evaluation of the Effects of Newcastle disease virus as an oncolytic virus on the expression of apoptosis-related genes in lung epithelial cell line","author":"Esfahani","year":"2025","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"10.1016\/j.ctarc.2026.101294_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1216674","article-title":"Probiotics: mechanism of action, health benefits and their application in food industries","volume":"14","author":"Latif","year":"2023","journal-title":"Front. Microbiol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101294_bib0014","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3390\/microorganisms10030533","article-title":"Anti-tumor effects of heat-killed L. reuteri MG5346 and L. casei MG4584 against human colorectal carcinoma through caspase-9-dependent apoptosis in xenograft model","volume":"10","author":"Kim","year":"2022","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101294_bib0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2174\/0115733947270529231116114913","article-title":"Alterations of the gut microbiome and metabolome following: a opportunity for early detection of colorectal cancer","volume":"21","author":"Modarres","year":"2025","journal-title":"Curr. Cancer Ther. Rev."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101294_bib0016","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.3390\/biology11111642","article-title":"The pivotal role of the gut microbiome in colorectal cancer","volume":"11","author":"Siddiqui","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.ctarc.2026.101294_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1296447","article-title":"Role of probiotics in managing various human diseases, from oral pathology to cancer and gastrointestinal diseases","volume":"14","author":"Petrariu","year":"2024","journal-title":"Front. Microbiol."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101294_bib0018","doi-asserted-by":"crossref","first-page":"525","DOI":"10.37201\/req\/058.2021","article-title":"Overview of virus and cancer relationships","volume":"34","author":"Bouza","year":"2021","journal-title":"Rev. Esp. Quimioter."},{"key":"10.1016\/j.ctarc.2026.101294_bib0019","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fonc.2017.00195","article-title":"Oncolytic viruses\u2014interaction of virus and tumor cells in the battle to eliminate cancer","volume":"7","author":"Howells","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ctarc.2026.101294_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115627","article-title":"Advancements and challenges in oncolytic virus therapy for gastrointestinal tumors","volume":"168","author":"Li","year":"2023","journal-title":"Biomed. PharmacOther"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101294_bib0021","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1207\/S15327914NC4602_13","article-title":"Cell cycle dysregulation induced by cytoplasm of Lactococcus lactis ssp. lactis in SNUC2A, a colon cancer cell line","volume":"46","author":"Kim","year":"2003","journal-title":"Nutr. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101294_bib0022","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4142\/jvs.2004.5.1.41","article-title":"Immunomodulatory and antitumor effects in vivo by the cytoplasmic fraction of Lactobacillus casei and Bifidobacterium longum","volume":"5","author":"Lee","year":"2004","journal-title":"J. Vet. Sci."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101294_bib0023","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/01635580903407197","article-title":"Probiotic Lactobacillus acidophilus and L. casei mix sensitize colorectal tumoral cells to 5-fluorouracil-induced apoptosis","volume":"62","author":"Baldwin\u2217","year":"2010","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.ctarc.2026.101294_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.788040","article-title":"Effects of Lactobacillus acidophilus KLDS1. 0901 on proliferation and apoptosis of colon cancer cells","volume":"12","author":"Yue","year":"2022","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101294_bib0025","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/cancers13010020","article-title":"The role of probiotics in cancer prevention","volume":"13","author":"\u015ali\u017cewska","year":"2020","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101294_bib0026","first-page":"839","article-title":"Inhibitory effects of probiotic Bacillus coagulans against MCF7 breast cancer cells","volume":"13","author":"Dolati","year":"2021","journal-title":"Iran. J. Microbiol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101294_bib0027","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3535982","article-title":"The role of probiotics in colorectal cancer management","volume":"2020","author":"Sivamaruthi","year":"2020","journal-title":"Evid Based Complement Altern. Med"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101294_bib0028","first-page":"97","article-title":"Synergistic effects of Bacillus coagulans and Newcastle disease virus on human colorectal adenocarcinoma cell proliferation","volume":"16","author":"Gouvarchinghaleh","year":"2024","journal-title":"Iran. J. Microbiol."},{"key":"10.1016\/j.ctarc.2026.101294_bib0029","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.actatropica.2018.04.007","article-title":"Newcastle disease virus strain AF2240 as an oncolytic virus: a review","volume":"183","author":"Kalyanasundram","year":"2018","journal-title":"Acta Trop."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101294_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195425","article-title":"Oncolytic effect of wild-type Newcastle disease virus isolates in cancer cell lines in vitro and in vivo on xenograft model","volume":"13","author":"Yurchenko","year":"2018","journal-title":"Plos. One"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101294_bib0031","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-51465-6","article-title":"Antiviral interferons induced by Newcastle disease virus (NDV) drive a tumor-selective apoptosis","volume":"9","author":"Ginting","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101294_bib0032","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.sjbs.2019.04.015","article-title":"Oncolytic Newcastle disease virus reduces growth of cervical cancer cell by inducing apoptosis","volume":"27","author":"Keshavarz","year":"2020","journal-title":"Saudi. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101294_bib0033","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/s12935-020-01514-2","article-title":"Hexokinase inhibition using D-Mannoheptulose enhances oncolytic newcastle disease virus-mediated killing of breast cancer cells","volume":"20","author":"Al-Ziaydi","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101294_bib0034","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12985-018-0975-x","article-title":"Oncolytic activity of a coxsackievirus B3 strain in human endometrial cancer cell lines","volume":"15","author":"Lin","year":"2018","journal-title":"Virol. J."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101294_bib0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1535-6108(03)00170-3","article-title":"Getting oncolytic virus therapies off the ground","volume":"4","author":"Bell","year":"2003","journal-title":"Cancer Cell"},{"issue":"23","key":"10.1016\/j.ctarc.2026.101294_bib0036","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01386-18","article-title":"A novel chimeric oncolytic virus vector for improved safety and efficacy as a platform for the treatment of hepatocellular carcinoma","volume":"92","author":"Abdullahi","year":"2018","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.ctarc.2026.101294_bib0037","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/cgt.2008.31","article-title":"Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors","volume":"15","author":"Yaacov","year":"2008","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.ctarc.2026.101294_bib0038","article-title":"Functional transcriptome analysis of bladder cancer cell lines persistently infected with oncolytic newcastle disease virus","author":"Ahmad","year":"2020","journal-title":"BioRxiv"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101294_bib0039","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13287-016-0414-0","article-title":"Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL","volume":"7","author":"Kazimirsky","year":"2016","journal-title":"Stem Cell Res. Ther."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101294_bib0040","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-71746-z","article-title":"Sex differences in adverse events among cancer patients receiving immune checkpoint inhibitors: the MOUSEION-07 systematic review and meta-analysis","volume":"14","author":"Vitale","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ctarc.2026.101294_bib0041","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.clnesp.2025.03.023","article-title":"Prognostic significance of the cachexia index (CXI) in patients with cancer: a systematic review and meta-analysis","volume":"68","author":"Bas","year":"2025","journal-title":"Clin. Nutr. ESPEN."},{"issue":"21","key":"10.1016\/j.ctarc.2026.101294_bib0042","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.3390\/cancers16213689","article-title":"Prognostic value of neutrophil-to-eosinophil ratio (NER) in cancer: a systematic review and meta-analysis","volume":"16","author":"Sahin","year":"2024","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101294_bib0043","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1186\/s12885-024-13011-0","article-title":"Newcastle disease virus enhances the antitumor efficacy of Doxorubicin in a cervical cancer mouse model","volume":"24","author":"Rasekhi Kazeruni","year":"2024","journal-title":"BMC. Cancer"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226002054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226002054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:57:33Z","timestamp":1790913453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226002054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":43,"alternative-id":["S2468294226002054"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101294","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comparative analysis of cytotoxic effects: Lactobacillus reuteri Extract vs. Newcastle Disease Virus in human colorectal cancer (HT-29 cell line)","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101294","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101294"}}